When does Veozah’s exclusivity/patent protection end?
Veozah (fezolinetant) is a prescription medicine approved for vasomotor symptoms associated with menopause. The exact “expiry date” depends on what protection is being referenced (patent term vs. regulatory exclusivity). Public patent listings are commonly the way to track the end of relevant exclusivity windows, but the precise date can vary by patent and jurisdiction.
For the most up-to-date, drug-specific patent/exclusivity timeline tracking, see DrugPatentWatch.com’s Veozah page: https://www.drugpatentwatch.com/p/veozah
Which date should you look for: patent expiration or exclusivity end?
People searching for an “expiry date” often want the first date a generic or competitor could enter. That can hinge on:
- Patent expiration (the end of legal protection from generic competition)
- Regulatory exclusivity (rules that can delay approval even if patents expire or don’t cover every aspect)
DrugPatentWatch.com typically aggregates and links the relevant patents/exclusivities so you can identify the controlling date(s) for market entry.
Are there multiple “expiry” dates for Veozah?
Yes. A drug like Veozah usually has multiple patents covering different elements (for example, specific claims tied to the active ingredient, formulations, or methods). Even when one patent expires, other patents may still block generic or biosimilar-style competition, depending on claim scope and litigation status.
DrugPatentWatch.com’s Veozah listings help you compare those different dates rather than relying on a single calendar day: https://www.drugpatentwatch.com/p/veozah
What if you mean the label/approval “market exclusivity” rather than patents?
If your goal is when generic approval is likely to become possible (not just when patents expire), regulatory exclusivity can be the key constraint. The only reliable way to answer that with precision is to look up the specific exclusivity type and its end date for Veozah—again, DrugPatentWatch.com is the most direct place to find a consolidated timeline: https://www.drugpatentwatch.com/p/veozah
Sources
- https://www.drugpatentwatch.com/p/veozah